Ziopharm Oncology reported $9.07M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Amgen AMGN:US $ 1.38B 130M
Arena Pharmaceuticals ARNA:US $ 31.94M 2.48M
AstraZeneca AZN:LN 2.57B 76M
Baxter International BAX:US $ 648M 44M
Biogen BIIB:US $ 654.1M 16.8M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Corcept Therapeutics CORT:US $ 30.03M 520K
Curis CRIS:US $ 4.07M 56K
Eleven Biotherapeutics EBIO:US 6.8M 1.51M
Gilead Sciences GILD:US $ 1.34B 297M
GlaxoSmithKline GSK:LN 2.5B 183M
Immunogen IMGN:US $ 9.73M 481K
Intercept Pharmaceuticals ICPT:US $ 57.65M 1.62M
Intrexon XON:US $ 20M 1.3M
IONIS PHARMACEUT IONS:US $ 56.46M 4.74M
Johnson & Johnson JNJ:US $ 6B 73M
Karyopharm Therapeutics KPTI:US $ 36.53M 1.12M
Merk MRK:US $ 2.25B 376M
Novartis NOVN:VX 3.71B 190M
Pfizer PFE:US $ 2.79B 134M
Ptc Therapeutics PTCT:US $ 68.88M 7.78M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Sangamo Biosciences SGMO:US $ 16.49M 338K
Tg Therapeutics TGTX:US $ 34.02M 7.26M
Verastem VSTM:US $ 6.71M 496K
YTE INCY:US $ 168.86M 15.06M
Ziopharm Oncology ZIOP:US $ 9.07M 842K